1-2 of 2
Estela Moreno
Close
Sort by
Journal Articles

Intravenous Once-Daily BuCy 2 With Pharmacokinetic (PK)-Guided Dose Adjustment As Conditioning Regimen For AML Patients In First Complete Remission

Felipe Suarez, MD, Philippe Bourget, PhD, Emilio Paolo Alessandrino, MD, Mario Regazzi, PhD, Gérard Socié, MD, PhD, Mauricette Michallet, MD, PhD, Jérôme Guitton, PHD, Sebastien Wittnebel, MD, Angelo Paci, PHD, Didier Blaise, MD, Bénédicte Devictor, PHD, Ana Berceanu, MD, Véronique Kemmel, PHD, Jorge Sierra, MD, PhD, Maria Estela Moreno Martinez, PHD, Ambroise Marcais, MD, Alexandre Amin, PHD, Anna Amelia Colombo, MD, Francesco Ripamonti, MD, de Latour Régis Peffault, MD, Nathalie Dhedin, MD, Alienor Xhaard, MD, Hélène Labussière-Wallet, MD, Franck E Nicolini, MD, PhD, Marie Y. Detrait, MD, Sophie Ducastelle, MD, Xavier Thomas, MD, Jean-Henri Bourhis, MD, PhD, Gonzalo Ferrini, PHD, Sabine Furst, MD, Bruno Lioure, MD, Rodrigo Martino, MD, PhD, Mireia Riba, PH, Anna Feliu, PHD, Carole Levrault, Marcello Riggi, MD, PhD, Christine Ta Thanh Minh, MD
Journal: Blood
Blood (2013) 122 (21): 4566.
https://doi.org/10.1182/blood.V122.21.4566.4566
Published: 2013
Journal Articles

Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation Using Oral Fludarabine as Part of the Conditioning Regimen.

Julio Delgado, Ana Marco, Estela Moreno, Jose L. Pinana, David Valcarcel, Rocio Parody, Blanca Sanchez-Gonzalez, Rodrigo Martino, Javier Briones, Anna Sureda, Salut Brunet, Jorge Sierra
Journal: Blood
Blood (2007) 110 (11): 4925.
https://doi.org/10.1182/blood.V110.11.4925.4925
Published: 2007